Juvenile Paget disease (JPD) is a very rare disease, mainly caused by biallelic inactivating mutations in the TNFRSF11B gene that encodes osteoprotegerin. Owing to its rarity, the treatment of JPD is ...

The U.S. Food and Drug Administration has approved expanded use of Amgen's drug, Uplizna, to help reduce the risk of flares in patients with a rare immune system-related condition, the regulator said ...

“People have been scarred by this pandemic in the form of long COVID, and their disease is real and requires ... prevention, and treatment and AHRQ’s Long COVID Care Network (an initiative ...

March 24, 2025 – The FDA has approved a new Crohn’s disease treatment called guselkumab, which, unlike similar drugs, can be given via self-injection by patients at home, provided their ...

Scientists have found a potential new gene variant target to treat sickle cell disease, an inherited blood disorder that affects about 300,000 people globally each year, with limited treatment options ...

The course emphasized an integrated approach to managing tuberculosis patients, including those with drug-resistant forms of the disease and latent tuberculosis infections. This holistic method, which ...

About half of all people with untreated active TB die from the disease, whereas treatment reduces the death rate to 12 percent. One of the more colorful phrases describing TB is “the king’s ...

Now, the personalized treatment is poised to touch millions of lives. Parkinson’s disease diagnoses have doubled since the 1990s, affecting 10 million people around the world, including “Back ...

Recent early clinical study data in autoimmune diseases suggest that deep B-cell depletion might have the potential to reset the adaptive immune system, leading to sustained treatment-free ...

Sanofi said it would acquire Bispecific Myeloid Cell Engager, an autoimmune disease treatment, from Dren Bio, for up to $1.9 billion. The French pharmaceutical company on Thursday said it would ...

Get Instant Summarized Text (Gist) An enzyme, lactate dehydrogenase (BbLDH), has been identified as a promising target for developing new treatments for Lyme disease. BbLDH is crucial for the ...

Cashin, the author of the analysis, insists that “the results of the review help clarify which treatments have a specific effect and are worth considering.” He also emphasizes that more research is ...